EORTC protocol 55863

Randomized phase III trial of vindesine, Cisplatin, bleomycin and mitomycin-C (BEMP) versus Cisplatin (P) in disseminated squamous cell carcinoma of the uterine cervix
Trial StatusAll trial activities ended
DatesDate of activation: 15-Sep-86
Closed on : 03-Jun-96
Data management at EORTCFull
Phase3
Randomized trialYes
TypeAdvanced
Targeted Sample size140
Number of steps1
Drug
Study StaffNicoletta Colombo (Study Coordinator) - Istituto Europeo Di Oncologia, Milano
Jan Baptist Vermorken (Study Coordinator) - Universitair Ziekenhuis Antwerpen, Edegem
Type of cancerCervical
Participating GroupsEORTC Gynecological Cancer Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
Back to Protocol section